Showing results (1201-1210 of 1,238) with videos related to

Sort By:
Pageof 124
Clinical Therapeutics|October 14, 2022
A Multicenter, Randomized, Double-blind, Active-controlled, Factorial Design, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of Pitavastatin and Ezetimibe Versus Monotherapy of Pitavastatin in Patients With Primary HypercholesterolemiaHan Saem Jeong, Soon Jun Hong, Jin-Man Cho, et al.
Journal of Neurointerventional Surgery|May 22, 2026
AI assisted detection of large vessel occlusion on non-contrast CT: multinational validation and reader studyLeonard Sunwoo, Wi-Sun Ryu, Karen Buch, et al.
Annals of Surgery|September 15, 2018
Surgical Outcomes of Hepatocellular Carcinoma With Bile Duct Tumor Thrombus: A Korea-Japan Multicenter StudyDong-Sik Kim, Bong-Wan Kim, Etsuro Hatano, et al.
Clinical Therapeutics|April 21, 2018
Efficacy and Safety of Fixed-dose Combination Therapy With Telmisartan and Rosuvastatin in Korean Patients With Hypertension and Dyslipidemia: TELSTA-YU (TELmisartan-rosuvaSTAtin from YUhan), a Multicenter, Randomized, 4-arm, Double-blind, Placebo-controlled, Phase III StudyGyu Chul Oh, Jung-Kyu Han, Ki Hoon Han, et al.
ACS Nano|February 18, 2026
Advances and Future Challenges in Monolithic 3D Integrated Logic, Power, and Optoelectronics Technologies for Tightly Interconnected Intelligent SystemsHaksoon Jung, Joonghoon Choi, Seunghun Baek, et al.
American Journal of Human Genetics|March 26, 2024
Detection of elusive DNA copy-number variations in hereditary disease and cancer through the use of noncoding and off-target sequencing readsMathieu Quinodoz, Karolina Kaminska, Francesca Cancellieri, et al.
Journal of Korean Medical Science|March 22, 2022
A Multi-Center, Double-Blind Randomized Controlled Phase III Clinical Trial to Evaluate the Antiviral Activity and Safety of DA-2802 (Tenofovir Disoproxil Orotate) and Viread (Tenofovir Disoproxil Fumarate) in Chronic Hepatitis B PatientsHyung Joon Kim, Ju Hyun Kim, Jong Eun Yeon, et al.
Experimental & Molecular Medicine|February 29, 2024
Synergistic toxicity with copper contributes to NAT2-associated isoniazid toxicityJihoon G Yoon, Dong Geon Jang, Sung-Gyu Cho, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 7, 2019
Clinical implication of tumor site in terms of node metastasis for intrahepatic cholangiocarcinomaWoohyung Lee, Chi-Young Jeong, Jae Yool Jang, et al.
Clinical Therapeutics|December 11, 2017
Efficacy and Safety of Adding Omega-3 Fatty Acids in Statin-treated Patients with Residual Hypertriglyceridemia: ROMANTIC (Rosuvastatin-OMAcor iN residual hyperTrIglyCeridemia), a Randomized, Double-blind, and Placebo-controlled TrialChee Hae Kim, Kyung Ah Han, Jaemyung Yu, et al.
Pageof 124